|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-8-25
|
|
pubmed:abstractText |
This study aimed to identify the baseline hepatitis B virus (HBV) DNA, alanine aminotransferase (ALT) levels and on-treatment HBV DNA levels for favourable outcome in patients receiving 5-year lamivudine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
679-85
|
|
pubmed:meshHeading |
pubmed-meshheading:19704171-Adolescent,
pubmed-meshheading:19704171-Adult,
pubmed-meshheading:19704171-Alanine Transaminase,
pubmed-meshheading:19704171-DNA, Viral,
pubmed-meshheading:19704171-Female,
pubmed-meshheading:19704171-Hepatitis B, Chronic,
pubmed-meshheading:19704171-Hepatitis B e Antigens,
pubmed-meshheading:19704171-Hepatitis B virus,
pubmed-meshheading:19704171-Humans,
pubmed-meshheading:19704171-Lamivudine,
pubmed-meshheading:19704171-Male,
pubmed-meshheading:19704171-Middle Aged,
pubmed-meshheading:19704171-Reverse Transcriptase Inhibitors,
pubmed-meshheading:19704171-Treatment Outcome,
pubmed-meshheading:19704171-Viral Load,
pubmed-meshheading:19704171-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
|
|
pubmed:affiliation |
Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong. mfyuen@hkucc.hku.hk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
